Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
MilliporeSigma (3)
69 Articles Available
3
3
Can't find what you're looking for? Try our
advanced search
.
Antibody–Drug Conjugates
Preparing for the ADC Explosion with End-to-End Support
PAP-Q4-20-CL-014
Gene Therapy
Anticipating the Next Decade of Gene Therapy
PAO-11-20-CL-02
Orally Disintegrating Tablets
Qualifying ODT Excipient Systems Beyond Disintegration Performance
PAO-10-20-CL-03
Wet Granulation
The Application of Mannitol In Wet Granulation
PAO-10-20-CL-01
Lipid Excipients
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies
PAP-Q3-20-CL-024
Clinical Trials
Celyad Oncology Announces Clinical Trial Collaboration to Evaluate CYAD-101 with KEYTRUDA
PR-M09-20-32
Expansion
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion
PR-M09-20-NI-14
Capacity Expansion
MilliporeSigma Invests $20 Million in New Switzerland Laboratory
PR-M07-20-NI-022
Depth Filtration
Robust Harvest Clarification for Adeno-Associated Viral Vectors via Depth Filtration
PAP-Q2-20-CL-030
Capacity Expansion
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility
PR-M04-20-NI-032
Purification
High-Productivity Membrane Chromatography to Enable Next-Generation Purification of Monoclonal Antibodies
PAP-Q4-19-CL-023
Biopharma
Bioprocess of the Future: What’s In it for Biomanufacturers?
PAP-Q2-2019-CL-026
M Lab
MilliporeSigma Opens First M Lab™ Collaboration Center in Europe
PR-M03-19-NI-060
CRISPR
MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M03-19-NI-009
Awards
MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018
PR-M11-18-NI-101
CRISPR
MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M09-18-NI-046
CRISPR
MilliporeSigma Receives Two More Patents for CRISPR Technology
PR-M02-18-NI-86
BioLife Solutions Executes OEM Agreement with MilliporeSigma
PR-M02-18-NI-57
Innovation
MilliporeSigma Expands Celonic's Upstream Capabilities with Mobius® Single-use Bioreactors
PR-M09-17-NI-004
CRISPR
MilliporeSigma Increases the Efficiency of Gene Editing
PAO-M05-17-NI-030
Innovation
Millipore Sigma Sponsoring LabCentral
PAO-M05-17-NI-002
«
3
3